Non-motor Clinical and Biomarker Predictors Enable High Cross-Validated Accuracy Detection of Early PD but Lesser Cross-Validated Accuracy Detection of Scans Without Evidence of Dopaminergic Deficit

Background: Early stage (preclinical) detection of Parkinson's disease (PD) remains challenged yet is crucial to both differentiate it from other disorders and facilitate timely administration of neuroprotective treatment as it becomes available. Objective: In a cross-validation paradigm, this...

Descripción completa

Detalles Bibliográficos
Autores principales: Leger, Charles, Herbert, Monique, DeSouza, Joseph F. X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232850/
https://www.ncbi.nlm.nih.gov/pubmed/32477243
http://dx.doi.org/10.3389/fneur.2020.00364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232850/
https://www.ncbi.nlm.nih.gov/pubmed/32477243
http://dx.doi.org/10.3389/fneur.2020.00364

Ejemplares similares